Royzen Lab | News
Maksim (Max) Royzen research into applications of bio-orthogonal chemistry for in vivo imaging and RNA synthesis.
Maksim Royzen, Max Royzen, RNA imaging, live cell imaging, TCO, tetrazine, trans-cyclooctene, UAlbany Chemistry, RNA Institute, bio-orthogonal, bioorthogonal, MNP, nanoparticle, HMT, hydrogel, soft tissue sarcoma, STS, doxorubicin, dox-TCO, RNA-protein interactions, PRE, paramagnetic NMR, RNA synthesis, drug delivery
15188
page,page-id-15188,page-template-default,ajax_fade,page_not_loaded,,qode-title-hidden,transparent_content,qode-theme-ver-9.5,wpb-js-composer js-comp-ver-4.12,vc_responsive

NEWS

8 DECEMBER 2018

ACS Cent Sci 2018

Our collaborative work with Shasqi, Inc., as well as collaborators from Berlin has just been accepted for publication by ACS Central Science. Congratulations to Eddie, Chris, Hasina, Ilenis and Dr. Khan!

5 DECEMBER 2018

NIH NIGMS 250x250_72dpi

We received another collaborative SBIR grant with Shasqi, Inc. We would like to thank the NIGMS institute of the NIH for their generous support. This will be a 3-year grant focused on the development of bio-orthogonal chemistry-based drug delivery strategies.

1 DECEMBER 2018

group_xunshen 250_250_72dpi

We welcome the new postdoctoral scientist, Xunshen Wu, who just joined the Royzen research group from China. Dr. Wu completed his doctoral work past summer at the East China University of Science and Technology.